Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT06042881
  4. Details
NCT06042881 Clinical Trial

Retrospective Cohort Study of the Physiotherapy in Critically Ill Covid Patients

COVID-19 Clinical Trial

Official title:
Retrospective Cohort Study of the Physiotherapy Procedure in Critically Ill Patients Diagnosed With COVID-19 During the First Wave

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06042881
Other study ID # IIBSP-COV-2022-36
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 23, 2023
Est. completion date October 30, 2023

Study information
Verified date September 2023
Source Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact Dolça Gras Pacheco
Phone +34684344258
Email dolcagras@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Retrospective cohort study that will include patients from the ICU of the Hospital de la Santa Creu i Sant Pau in Barcelona during the period between March 11 and May 13, 2020. The cohorts are made up of two groups of patients admitted for severe COVID during the first wave, according to whether or not they received physiotherapy and the possible impact of physiotherapy on the days of mechanical ventilation in the two study groups will be studied.

Recruitment information / eligibility
Status Recruiting
Enrollment 189
Est. completion date October 30, 2023
Est. primary completion date July 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients diagnosed with COVID-19 in critical condition - Adults >18 years - Admission to the ICU from March 11 to May 13, 2020 Exclusion Criteria: - Patients readmitted on 2 occasions during the study period, the second will be omitted income.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Spain Hospital de la Santa Creu i Sant Pau Barcelona

Sponsors (1)
Lead Sponsor Collaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Days of mechanical ventilation To evaluate the effectiveness of early physiotherapy in critically ill patients with COVID-19 admitted to the ICU in terms of reducing days of mechanical ventilation 2 months
Secondary days of stay Evaluate the days of stay in the ICU 2 months
Secondary Assess morbidity and mortality. Assess morbidity and mortality. 2 months
Secondary Assess the comorbidities of patients admitted for COVID-19 in critical condition Assess the comorbidities of patients admitted for COVID-19 in critical condition 2 months
Secondary PNS lesion in prono position To know if there is a greater risk of suffering a PNS lesion the more rounds of pronation 2 months
Secondary Assess the comorbidities of patients admitted for COVID-19 in critical condition To know if the delay in the prescription of physiotherapy (FST) influences the appearance of PNS lesions. 2 months
Secondary Start of standing in critrically ill To evaluate the start of standing (BP) in critically ill patients infected with COVID-19 who underwent FST. 2 months
Secondary Workload in physiotherapy To assess the workload of the cohort of patients who underwent physiotherapy during the first wave of COVID-19. 2 months
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure